A Transdisciplinary Panel on CRISPR/Cas9 2018-02-13 10:30:00

Back to Events

Start:Tuesday, 13 February 2018Time:10:30
End:Tuesday, 13 February 2018Time:12:30
Category: Non-SCS events

Science Policy Session sunt as part of commodo the LS2 Annual ea Meeting 2018:
- mollit Martin Jinek, University of quis Zurich
- Bruno in Lemaitre, EPF Lausanne
- anim Effy Vayena, Chair of enim Bioethics, Health Ethics culpa & Policy Lab, Dep. Ut of Health Sciences et & Technology, ETHZ)
- Heinz Müller, Swiss amet, Federal Institute of do Intellectual Property, Bern
Moderation: Nik Walter in (Tages-Anzeiger/SonntagsZeitung)

Venue: University of Lausanne, Amphimax/Amphipôle
Detailed DescriptionThe CRISPR/Cas9 revolution is widely being talked about these days. Apart from being a major scientific breakthrough, it also reveals how different fears and hopes are being handled by science, society, economy, and policy makers. The CRISPR/Cas9 system thus represents an ideal case to discuss the different implications of modern biomedical research, from economical, legal and ethical implications, to aspects of scientific impact and careers. The transdisciplinary panel will give the stage to experts from different fields to then discuss all these aspects around one technology.

Attendance to the panel only is free.
Please register for the panel until January, 5th, 2018 with an e-mail to info@ls2.ch
Email: Send
Website: http://www.annual-meeting.ls2.ch
Event Type
This event is public. Anyone can attend and invite others to attend.
Spichiger David (creator)